性别驱动因素对阿尔茨海默病风险的影响:多模态脑影像研究
该研究纳入121名40至65岁认知正常参与者(85名女性,36名男性),采用多模态脑影像(PiB-PET、FDG-PET、结构MRI)比较AD生物标志物的性别差异。调整混杂因素后,女性较男性表现出更高的β-淀粉样蛋白沉积、更低的葡萄糖代谢和更低的灰白质体积,且绝经状态是与这些差异最 consistently 相关的预测因素。结论提示激素风险因素(尤其是绝经)预测中年女性的AD内表型,女性AD预防干预的窗口期可能在内分泌衰老早期。
要点
- 中年女性较男性显示更高的PiB β-淀粉样蛋白沉积、更低的FDG代谢和更低的灰白质体积。
- 绝经状态是仅次于女性性别的最强预测因素,与脑生物标志物差异相关。
- 女性AD预防干预的窗口期可能在内分泌衰老早期。
核心结论
- 激素风险因素,尤其是绝经,预测中年女性的阿尔茨海默病内表型。
- 女性AD预防干预的机会窗口可能处于内分泌衰老过程的早期。
研究设计与样本
- 研究纳入121名40至65岁认知正常参与者,其中女性85名,男性36名。
- 参与者接受了临床、实验室、神经心理、生活方式、MRI、FDG-PET和PiB-PET检查。
- 采用统计参数映射和LASSO回归比较男女AD生物标志物并识别与性别差异相关的风险因素。
主要发现
- 调整各模态特定混杂因素后,女性组较男性组显示更高的PiB β-淀粉样蛋白沉积、更低的FDG葡萄糖代谢和更低的MRI灰质和白质体积(p < 0.05,经多重比较家族错误率校正)。
- 男性组较女性组未显示生物标志物异常。
- 结果独立于年龄,且在年龄匹配组中仍显著。
- 仅次于女性性别,绝经状态是与观察到的脑生物标志物差异最一致且最强相关的预测因素,其次是激素治疗、子宫切除状态和甲状腺疾病。
临床怎么用
- 对于中年女性,尤其是围绝经期女性,应关注阿尔茨海默病相关脑生物标志物改变的风险。
- 绝经状态可作为女性AD风险评估的重要参考因素。
- 女性AD预防干预宜考虑在内分泌衰老早期(如围绝经期)实施。
局限性
- 样本量较小(121人),且为认知正常中年人群,结果外推需谨慎。
- 横断面设计无法确定因果关系。
- 激素相关因素(如绝经状态)与脑生物标志物差异的关联机制未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate sex differences in late-onset Alzheimer disease (AD) risks by means of multimodality brain biomarkers (β-amyloid load via 11C-Pittsburgh compound B [PiB] PET, neurodegeneration via 18F-fluorodeoxyglucose [FDG] PET and structural MRI). METHODS: We examined 121 cognitively normal participants (85 women and 36 men) 40 to 65 years of age with clinical, laboratory, neuropsychological, lifestyle, MRI, FDG- and PiB-PET examinations. Several clinical (e.g., age, education, APOE status, family history), medical (e.g., depression, diabetes mellitus, hyperlipidemia), hormonal (e.g., thyroid disease, menopause), and lifestyle AD risk factors (e.g., smoking, diet, exercise, intellectual activity) were assessed. Statistical parametric mapping and least absolute shrinkage and selection operator regressions were used to compare AD biomarkers between men and women and to identify the risk factors associated with sex-related differences. RESULTS: Groups were comparable on clinical and cognitive measures. After adjustment for each modality-specific confounders, the female group showed higher PiB β-amyloid deposition, lower FDG glucose metabolism, and lower MRI gray and white matter volumes compared to the male group (p < 0.05, family-wise error corrected for multiple comparisons). The male group did not show biomarker abnormalities compared to the female group. Results were independent of age and remained significant with the use of age-matched groups. Second to female sex, menopausal status was the predictor most consistently and strongly associated with the observed brain biomarker differences, followed by hormone therapy, hysterectomy status, and thyroid disease. CONCLUSION: Hormonal risk factors, in particular menopause, predict AD endophenotype in middle-aged women. These findings suggest that the window of opportunity for AD preventive interventions in women is early in the endocrine aging process.
引用
- Rahman A, Schelbaum E, Hoffman K, et al. Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study. Neurology. 2020. PMID: 32580974. doi:10.1212/WNL.0000000000009781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。